Clinical Trial Update: Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety and tolerability of BCA101 as monotherapy and in combination in EGFR-driven advanced solid tumors. The trial is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Cutaneous Squamous Cell Carcinoma
• Epithelial Ovarian Cancer
• Head and Neck Neoplasms
• Head and Neck Squamous Cell Carcinoma
• Pancreatic Cancer
• Squamous Cell Carcinoma of Anal Canal
• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• BCA101

Snippet

Sponsor: Bicara Therapeutics | Conditions: Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of Anal Canal | Phase 1 | Status: RECRUITING